Sort
17,288 grants matching “multiple sclerosis”
EFFECT OF ORAL PROVENTIL ON IL 12 SECRETION BY MONOCYTES IN MS PATIENTS
$0Brigham And Women'S Hospital · M01 · FY2001 · RR
TREATMENT OF MULIPLE SCLEROSIS BY ORAL TOLERIZATION TO MYELIN ANTIGEN
$0Brigham And Women'S Hospital · M01 · FY2001 · RR
Leveraging nanotechnology and skin delivery to drive selective immune tolerance for Multiple Sclerosis
$0Robert Smith Oakes · Baltimore Va Medical Center · IK2 · FY2024 · VA
ShEEP Request for Ultrafast Ultrasound for Brain Imaging in Freely Behaving Animals
$0Charles Kenneth Meshul · Portland Va Medical Center · IS1 · FY2019 · VA
MYCOPHENOLATE MOFETIL IN TRANSITIONAL MULTIPLE SCLEROSIS
$0Brigham And Women'S Hospital · M01 · FY2001 · RR
Cytokines in pathogenesis /treatment of autoimmune disea
$0Niaid Extramural Activities · Z01 · FY2004 · AI
Glycoproteins And Glycolipids Associated With Myelin In
$0Neurological Disorders And Stroke · Z01 · FY2004 · NS
IMMUNOLOGICAL STUDIES IN MULTIPLE SCLEROSIS
$0Rockefeller University · M01 · FY2001 · RR
Developmental Control Of Gene Expression In The Brain
$0Neurological Disorders And Stroke · Z01 · FY2004 · NS
SYNTHESIS
$0North Dakota State University · P20 · FY2001 · RR
Improving the Assessment of Myelin and Axonal Integrity in Early Multiple Sclerosis
$0Francesca Rosaria Bagnato · Veterans Health Administration · I01 · FY2023 · VA
Novel EPO peptide therapy for chronic rmTBI dependent neurodegeneration and neuroinflammation
$0Yun-Beom Choi · Va New Jersey Health Care System · I01 · FY2021 · VA
TARGETING AND DELIVERY
$0North Dakota State University · P20 · FY2001 · RR
Does Epstein-Barr Virus(EBV)Cause Systemic Lupus Erythematosus SLE)?
$0John Barker Harley · Cincinnati Va Medical Center Research · I01 · FY2025 · VA
Cognitive Rehabilitation of OIF/OEF Veterans with Cognitive Disorder
$0Daniel M Storzbach · Portland Va Medical Center · I01 · FY2014 · VA
Role of HLA Class-II Polymorphism in the Regulation of Host-Microbiota Symbiosis
$0Ashutosh Kumar Mangalam · Iowa City Va Medical Center · I01 · FY2025 · VA
Leveraging nanotechnology and skin delivery to drive selective immune tolerance for Multiple Sclerosis
$0Robert Smith Oakes · Baltimore Va Medical Center · IK2 · FY2021 · VA
CEREBROSPINAL STUDIES IN MULTIPLE SCLEROSIS
$0Brigham And Women'S Hospital · M01 · FY2000 · RR
Research-Dedicated Magnetic Resonance Imaging at McGuire VA Medical Center
$0Jose Francisco Huizar · Va Veterans Administration Hospital · IS1 · FY2021 · VA
Retinal microvasculature as a predictor of neurodegeneration in multiple sclerosis
$0Elizabeth Silbermann · Portland Va Medical Center · IK2 · FY2023 · VA
Novel EPO peptide therapy for chronic rmTBI dependent neurodegeneration and neuroinflammation
$0Yun-Beom Choi · Va New Jersey Health Care System · I01 · FY2025 · VA
Toward Closed-Loop Control of Homeostatic Blood Pressure Following Spinal Cord Injury
$0Matthew Anthony Schiefer · Veterans Health Administration · I21 · FY2021 · VA
Identification and Repair of Novel Axonal Pathology in Demyelinating Disease
$0Jeffrey L. Dupree · Va Veterans Administration Hospital · I01 · FY2015 · VA
Targeting spermine oxidase to prevent vision loss in Multiple Sclerosis
$0Priya Narayanan · Charlie Norwood Va Medical Center · I01 · FY2025 · VA
Quantitation of myelin damage in optic nerve, brainstem, cervical spinal cord, and corpus-callosum in MS
$0Eun-Kee Jeong · Va Salt Lake City Healthcare System · I01 · FY2025 · VA